MarketBeat
09 Aug 2026, 11:04 UTC · 11w ago
Trulieve Cannabis Q2 Earnings Call Highlights
Impact · against what's priced in
Trulieve's shift toward a US-domiciled NYSE listing and expansion into Texas and Georgia provide material catalysts for revenue growth and lower cost of capital. However, the positive momentum is partially offset by a reduction in full-year operating cash flow guidance.
- TRLV+0.40
No priced-in read yet
- In context
The NYSE listing and US re-domiciliation are expected to reduce the cost of capital, while tripled dispensary traffic in Georgia and a retail pipeline covering all 11 Texas regions offer concrete paths for top-line growth. These gains are tempered by a lowered full-year operating cash flow outlook of at least $225 million.
Read from the article alone
